Code | 8128E | ||||||||||
MA number | EU/1/24/1868/031 | ||||||||||
Product Form: | cps dur 14x3 mg (blis.PVC/PCTFE/PVC/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | TEVA GmbH, Germany | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 14.11.2024 |
Validity: | 14.11.2029 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | Pomalidomid_Prirucka pre zdravotnickych pracovnikov.pdf |
Dokument: | Pomalidomid_Prirucka pre pacientov.pdf |
Dokument: | Pomalidomid_Formulár informovanosti o rizikách.pdf |
Safety feature | Yes |
Data update: | 27.11.2024 |